Dandelion Root Extract in Patients with Refractory Hematologic Malignancies

Trial Status:	Closed
Start Date:	April, 2013
Expected Enrolment:	30
Type of Trial:	Treatment
Protocol IDs:	OCT1226, DRE
Trial Design:	None specified
Trial Phase:	Phase 1
Medical Conditions:	None specified
Drugs:	N/A
Lead Sponsor:	Lotte & John Hecht Memorial Foundation
Sponsors/Study Groups:	Lotte & John Hecht Memorial Foundation
Type of Treatment:	None specified
Principal Investigator(s):	Caroline Hamm, MD, Windsor Regional Cancer Center
Date posted on clinicaltrials.gov:	March 5, 2013
Last updated:	November 14, 2018

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

These resources are provided in partnership with the Canadian Cancer Society